Achaogen Inc

William Blair Boosts Price Target for Achaogen Inc (AKAO) as EPIC and CARE Top-Line Data Exceeds Expectations

Achaogen Inc (NASDAQ:AKAO) shares rose 14% today after the company┬áreported positive top-line results from the phase 3 trial of its treatment for urinary …

Tuesday’s Volatile Stocks: Analysts Weigh in on Achaogen Inc (AKAO) and Proteon Therapeutics Inc (PRTO)

Achaogen Inc (NASDAQ:AKAO) investors are partying around after the company announced surprisingly positive results from both Phase 3 trials of plazomicin in CRE …

Needham’s Alan Carr Turns Bullish on Achaogen Inc (AKAO); Here’s Why

Achaogen Inc (NASDAQ:AKAO) shares were shooting through the roof at 148% yesterday after the biotech firm pleasantly surprised investors with two Phase 3 …

Stock Update (NASDAQ:AKAO): Achaogen Inc Announces Positive Results in Phase 3 cUTI and CRE Clinical Trials of Plazomicin

Achaogen Inc (NASDAQ:AKAO) announced that its lead product candidate, plazomicin, met the objective of non-inferiority compared to meropenem for the U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts